The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: A double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study

American Journal of Clinical Nutrition

Volumn 80, Issue 6, 2004, Pages 1658-1664

  Bouhnik, Yoram ^a   Raskine, Laurent ^a   Simoneau, Guy ^a   Vicaut, Eric ^b   Neut, Christel ^c   Flourié, Bernard ^d   Brouns, Fred ^e,f   Bornet, Francis R ^g  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔPITAL FERNAND WIDAL   (France)

^c UNIV LILLE   (France)

^d University Hospital of Lyon South   (France)

^e Cerestar R and D Center   (Belgium)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g Nutri Health SA   (France)

Author keywords

Bifidobacterium; Gut flora; Human fecal microflora; Nondigestible carbohydrate; Oligosaccharides; Prebiotics; Randomized controlled trial

Indexed keywords

CARBOHYDRATE DERIVATIVE; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; INULIN; ISOMALTOOLIGOSACCHARIDE; LACTULOSE; OLIGOSACCHARIDE; PREBIOTIC AGENT; STARCH; UNCLASSIFIED DRUG; IDOLAX;

ARTICLE; BIFIDOBACTERIUM; CONTROLLED STUDY; DOSE RESPONSE; FECES MICROFLORA; HUMAN; NORMAL HUMAN; RANDOMIZATION; SOYBEAN; ADOLESCENT; ADULT; BACTERIAL COUNT; CLINICAL TRIAL; COLON; CONTROLLED CLINICAL TRIAL; DIETARY FIBER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FECES; FEMALE; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PH; RANDOMIZED CONTROLLED TRIAL;

BIFIDOBACTERIUM; GLYCINE MAX;

ADOLESCENT; ADULT; BIFIDOBACTERIUM; COLON; COLONY COUNT, MICROBIAL; DIETARY FIBER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FECES; FEMALE; FERMENTATION; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OLIGOSACCHARIDES; SOYBEANS; STARCH;

EID: 16544392539     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.6.1658     Document Type: Article

References (33)

1. Finegold SM, Sutter VL, Mathisen GE. Normal indigenous intestinal flora. In: Hentges DJ, ed. Human intestinal microflora in health and disease. New York: Academic Press, 1983:3-31.
2. Cummings JH, Macfarlane GT. Colonic microflora: nutrition and health. Nutrition 1997;13:476-8.
3. Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998;80:S147-71.
4. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401-12.
5. Playne MJ, Crittenden R. Commercially available oligosaccharides. Bull Int Dairy Fed 1996;313:10-22.
6. Saarela M, Lahteenmaki L, Crittenden R, Salminen S, Mattila-Sandholm T. Gut bacteria and health foods-the European perspective. Int J Food Microbiol 2002;15:99-117.
7. Rycroft CE, Jones MR, Gibson GR, Rastall RA. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 2001;91:878-87.
8. Grizard D, Barthomeuf C. Non-digestible oligosaccharides used as prebiotic agents: mode of production and beneficial effects on animal and human health. Reprod Nutr Dev 1999;39:563-88.
9. Bouhnik Y, Pochart P, Marteau P, Arlet G, Goderel I, Rambaud JC. Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastroenterology 1992;102:875-8.
10. Bouhnik Y, Flourié B, Riottot M, et al. Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans. Nutr Cancer 1996;26:21-9.
11. Bouhnik Y, Vahedi K, Achour L, et al. Short chain fructo-oligosaccharides administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr 1999;129:113-6.
12. Ito M, Deguchi Y, Matsumoto K, Kimura M, Onodera N, Yajima T. Influence of transgalacto-oligosaccharides on the human fecal microflora. J Nutr Sci Vitaminol (Tokyo) 1993;39:635-40.
13. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995;108:975-82.
14. Buddington RK, Williams CH, Chen SC, Witherly SA. Dietary supplement of Neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 1996;63:709-16.
15. Bouhnik Y, Flourié B, D'Agay-Abensour L, et al. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr 1997;127:444-8.
16. Alles MS, Hartemink R, Meyboom S, et al. Effect of transgalacto- oligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer. Am J Clin Nutr 1999;69:980-91.
17. Hayakawa K, Mizutani J, Wada K, Masai T, Yoshihara I, Mitsuoka T. Effects of soybean oligosaccharides on human fecal microflora. Microb Ecol Health Dis 1990;3:293-303.
18. Ito M, Deguchi Y, Miyamori A, et al. Effects of administration of galactooligosaccharides on the human fecal microflora, stool weight and abdominal sensation. Microb Ecol Health Dis 1990;3:285-92.
19. Bouhnik Y, Attar A, Joly FA, Riottot M, Dyard F, Flourié B. Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. Eur J Clin Nutr 2004;58:462-6.
20. Kruse HP, Kleessen B, Blaut M. Effects of inulin on fecal bifidobacteria in human subjects. Br J Nutr 1999;82:375-82.
21. Kleessen B, Stoof G, Proll J, Schmiedl D, Noack J, Blaut M. Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats. J Anim Sci 1997;75:2453-62.
22. Silvi S, Rumney CJ, Cresci A, Rowland IR. Resistant starch modifies gut microflora and microbial metabolism in human flora-associated rats inoculated with faeces from Italian and UK donors. J Appl Microbiol 1999;86:521-30.
23. Kleessen B, Sykura B, Zunft HJ, Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 1997;65:1397-402.
24. Ballongue JC, Schumann, Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol 1997;32:41-4.
25. Terada A, Hara H, Katoaka M, Mitsuoka T. Effect of lactulose on the composition and metabolic activity of the human fecal flora. Microb Ecol Health Dis 1992;5:43-50.
26. Kohomoto T, Fukui F, Takaku H, Machida Y, Arai M, Mitsuoka T. Effect of IMO on human fecal flora. Bifidobacteria Microflora 1988;7:61-9.
27. Samelson SL, Nelson RL, Nyhus LM. Protective role of fecal pH in experimental colon carcinogenesis. J R Soc Med 1985;78:230-3.
28. Malhotra SL. Fecal urobilinogen levels and pH of stools in population groups with different incidence of cancer of the colon, and their possible role in its aetiology. J R Soc Med 1982;75:709-14.
29. Hidaka H, Eida T, Takizawa T, Tokunaga T, Tashiro Y. Effects of fructo-oligosaccharides on intestinal flora and human health. Bifidobacteria Microflora 1986;5:37-50.
30. Mitsuoka T. Intestinal bacteria and health. Tokyo: Harcourt Brace Jovanovich Japan Inc, 1978.
31. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988;29:1035-41.
32. Florent C, Flourié B, Leblond A, Rautureau M, Bernier JJ, Rambaud JC. Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest 1985;75:608-13.
33. Rumessen JJ, Bode S, Hamberg O, Gudmand-Hoyer E. Fructans of Jerusalem artichokes: intestinal transport, absorption, fermentation and influence on blood glucose, insulin and C-peptide responses in healthy subjects. Am J Clin Nutr 1990;52:675-81.